College of Pharmaceutical Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
Molecules. 2022 May 6;27(9):2981. doi: 10.3390/molecules27092981.
Colorectal cancer (CRC) is a usual digestive tract malignancy and the third main cause of cancer death around the world, with a high occurrence rate and mortality rate. Conventional therapies for CRC have certain side effects and restrictions. However, the exciting thing is that with the rapid development of nanotechnology, nanoparticles have gradually become more valuable drug delivery systems than traditional therapies because of their capacity to control drug release and target CRC. This also promotes the application of nano-drug targeted delivery systems in the therapy of CRC. Moreover, to make nanoparticles have a better colon targeting effect, many approaches have been used, including nanoparticles targeting CRC and in response to environmental signals. In this review, we focus on various targeting mechanisms of CRC-targeted nanoparticles and their latest research progress in the last three years, hoping to give researchers some inspiration on the design of CRC-targeted nanoparticles.
结直肠癌(CRC)是一种常见的消化道恶性肿瘤,也是全球癌症死亡的第三大主要原因,其发病率和死亡率都很高。CRC 的常规疗法有一定的副作用和局限性。然而,令人兴奋的是,随着纳米技术的快速发展,纳米颗粒逐渐成为比传统疗法更有价值的药物递送系统,因为它们能够控制药物释放并靶向 CRC。这也促进了纳米药物靶向递送系统在 CRC 治疗中的应用。此外,为了使纳米颗粒具有更好的结肠靶向效果,已经使用了许多方法,包括针对 CRC 的纳米颗粒靶向和对环境信号的响应。在这篇综述中,我们重点介绍了 CRC 靶向纳米颗粒的各种靶向机制及其在过去三年中的最新研究进展,希望能为研究人员设计 CRC 靶向纳米颗粒提供一些启示。